REPL vs GILD: Which Stock is Better?
Side-by-side comparison of Replimune Group Inc and Gilead Sciences Inc in 2026
REPL
Replimune Group Inc
—
GILD
Gilead Sciences Inc
$125.16
Key Metrics Comparison
| Metric | REPL | GILD | Winner |
|---|---|---|---|
| Market Cap | $825.73M | $160.15B | GILD |
| P/E Ratio | N/A | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze REPL
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is REPL or GILD a better investment?
Comparing REPL and GILD: Replimune Group Inc has a market cap of $825.73M while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between REPL and GILD?
REPL (Replimune Group Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: REPL or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: REPL or GILD?
Both REPL and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: REPL or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: REPL or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $825.73M for REPL.
Should I buy REPL or GILD in 2026?
Both REPL and GILD have investment merit. REPL trades at $N/A while GILD trades at $125.16. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between REPL and GILD stock?
Key differences: Market Cap ($825.73M vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy REPL or GILD in 2026?
The choice between REPL and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between REPL and GILD?
REPL (Replimune Group Inc) has a market cap of $825.73M, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.